Breathing in TB treatment: new inhaler trial seeks to fight lung infection
NCT ID NCT07073638
Summary
This study is testing a new inhaled treatment called RESP30TB for adults with newly diagnosed, drug-susceptible tuberculosis. Researchers want to see if breathing in this medicine is safe and if it starts killing TB bacteria in the lungs. The trial will enroll 24 participants to monitor side effects and measure early signs of effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
TASK Clinical Research Centre
RECRUITINGCape Town, Bellville, 7531, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.